![Perry Schiro](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Perry Schiro
Società | Posizione | Inizio | Fine |
---|---|---|---|
MiCareo, Inc.
![]() MiCareo, Inc. BiotechnologyHealth Technology MiCareo, Inc. provides tools for the analysis of rare cells. It circulates tumor cell platform does rare cell isolation and analysis for cancer prognosis, treatment development, and efficacy evaluation. The firm’s product MiSelect starts with whole blood labeled with any fluorescent cell surface antibody or cocktail of multiple antibodies. The company was founded by Perry Schiro and Daniel T. Chiu in 2011 and is headquartered in Taipei, Taiwan. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 | - |
Fondatore | 01/01/2011 | - |
Storia della carriera di Perry Schiro
Statistiche
Distribuzione geografica
Taiwan | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
MiCareo, Inc.
![]() MiCareo, Inc. BiotechnologyHealth Technology MiCareo, Inc. provides tools for the analysis of rare cells. It circulates tumor cell platform does rare cell isolation and analysis for cancer prognosis, treatment development, and efficacy evaluation. The firm’s product MiSelect starts with whole blood labeled with any fluorescent cell surface antibody or cocktail of multiple antibodies. The company was founded by Perry Schiro and Daniel T. Chiu in 2011 and is headquartered in Taipei, Taiwan. | Health Technology |
- Borsa valori
- Insiders
- Perry Schiro
- Esperienza